Pro-Dex Inc New (PDEX) Stock: Buy, Sell, or Hold?
PDEX - Pro-Dex Inc New
$62.81
2.96 (4.95%)
â˛
5d:
+1.71%
30d:
-6.83%
90d:
-0.18%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When PDEX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: PDEX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: PDEX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: PDEX is currently trading at $62.80, which is considered slightly low relative to its 30-day fair value range of $62.50 to $68.10.
Technical Outlook: Technically, PDEX is in a uptrend. Immediate support is located at $58.04, while resistance sits at $77.00. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: PDEX scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $70.00 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PDEX is in a uptrend. Immediate support is located at $58.04, while resistance sits at $77.00. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: PDEX scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $70.00 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$62.50 -
$68.10
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading below Wall St target ($70.00)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.50 -
$68.10
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$58.04
Resistance Level
$77.00
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.04
Wall Street Target
$70.00
(+11.5%)
Revenue Growth (YoY)
16.6%
Earnings Growth (YoY)
143.4%
Profit Margin
17.6%
Share & Embed Analysis
Last updated: September 12, 2026 11:20 PM ET
Data refreshes hourly during market hours. Next update: 12:20 AM
Data refreshes hourly during market hours. Next update: 12:20 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PDEX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
